Drugs / Dorzotimol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05973318 | Apr 2017 → Sep 2018 | open-angle glaucoma | Jadran Galenski laboratorij d.d. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dorzotimol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05973318 ↗ |
| Route | Other | “Posology and method of administration: Instillation into the conjunctival sac of 1 drop twice daily for 12 weeks.” NCT05973318 ↗ |